Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's average Book Value per Share Growth Rate was 55.30% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 22.00% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 46.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 7 years, the highest 3-Year average Book Value per Share Growth Rate of Oncosem Onkolojik Sistemlernayi ve Ticaret AS was 65.70% per year. The lowest was 22.00% per year. And the median was 62.20% per year.
Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Oncosem Onkolojik Sistemlernayi ve Ticaret AS 3-Year Book Growth Rate Related Terms
IST:ONCSM vs ABT, SYK, MDT: 3-Year Book Growth Rate Comparison
For the Medical Devices subindustry, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oncosem Onkolojik Sistemlernayi ve Ticaret AS 3-Year Book Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 3-Year Book Growth Rate falls into.
Oncosem Onkolojik Sistemlernayi ve Ticaret AS 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 22.00% mean?
Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) has a 3-Year Book Growth Rate of 22.00% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Oncosem Onkolojik Sistemlernayi ve Ticaret AS and its competitors. This is 65% below median its historical median of 62.20. Over the past decade, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 3-Year Book Growth Rate has ranged from 22.00 to 65.70. According to the industry distribution chart, Oncosem Onkolojik Sistemlernayi ve Ticaret AS ranks #88 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 11.6%.
Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 3-Year Book Growth Rate too high?
Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current 3-Year Book Growth Rate of 22.00% is 65% below median its 10-year median of 62.20. Over the past 10 years, this metric has ranged from a low of 22.00 to a high of 65.70. The Medical Devices & Instruments industry median 3-Year Book Growth Rate is 2.40. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's value of 22.00% is 816.7% above this industry median. Based on the distribution chart, Oncosem Onkolojik Sistemlernayi ve Ticaret AS ranks #88 out of 758 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Oncosem Onkolojik Sistemlernayi ve Ticaret AS has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 3-Year Book Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Oncosem Onkolojik Sistemlernayi ve Ticaret AS ranks #88 out of 758 companies for 3-Year Book Growth Rate. This places Oncosem Onkolojik Sistemlernayi ve Ticaret AS in the top 12% of its industry — outperforming the majority of peers. The industry median 3-Year Book Growth Rate is 2.40. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's value of 22.00% is 816.7% above this benchmark. Historically, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's own 3-Year Book Growth Rate has ranged from 22.00 to 65.70 over the past decade. While the company's 10-year median is 62.20 vs. the industry median of 2.40, Oncosem Onkolojik Sistemlernayi ve Ticaret AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Book Growth Rate among Medical Devices & Instruments companies is 2.40, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current 3-Year Book Growth Rate of 22.00% is 816.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Oncosem Onkolojik Sistemlernayi ve Ticaret AS and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Book Growth Rate is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current 3-Year Book Growth Rate is 22.00%, which is 65% below median its own 10-year median of 62.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) is currently considered Modestly Undervalued. The stock's GF Value™ is ₺270.15, compared to a current price of ₺198.40 — trading 26.6% below its estimated fair value. The current 3-Year Book Growth Rate is 22.00%, which is 65% below median its 10-year median of 62.20 and 816.7% above the Medical Devices & Instruments industry median of 2.40. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM), the current 3-Year Book Growth Rate is 22.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) Overvalued in 2026?
Based on GuruFocus' analysis, Oncosem Onkolojik Sistemlernayi ve Ticaret AS stock appears to be undervalued.
The current stock price of ₺198.40 is trading 26.6% below its estimated GF Value™ of ₺270.15.
GuruFocus considers Oncosem Onkolojik Sistemlernayi ve Ticaret AS to be Modestly Undervalued.
Key valuation signals for IST:ONCSM:
3-Year Book Growth Rate: 22.00% (65% below median its 10-year median of 62.20)
GF Value™: ₺270.15 vs. price of ₺198.40 (26.6% below fair value)
Industry Position: 816.7% above the Medical Devices & Instruments median (#88 of 758)
No single metric tells the full story. See the IST:ONCSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:ONCSM has been successfully added to your 
